World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
32272
World Ranking
10875
National Ranking
391

Giovanni Paganelli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Giovanni Paganelli sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 484 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Giovanni Paganelli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Giovanni Paganelli sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Giovanni Paganelli is affiliated with the Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori in Italy. Their research is primarily situated within the field of Medicine with a focus on several specialized subfields including Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research, and Epidemiology.

The scientist's work covers a variety of topics, notable among them are:

  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments

Giovanni Paganelli has contributed to multiple publications, with papers appearing frequently in certain scientific venues. Key publication venues include:

  • European Journal of Nuclear Medicine and Molecular Imaging
  • Journal of Clinical Oncology
  • Physica Medica
  • Frontiers in Oncology
  • Scientific Reports

Among their recent papers are:

  • Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients, 2020, European Journal of Nuclear Medicine and Molecular Imaging
  • Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study, 2020, European Journal of Nuclear Medicine and Molecular Imaging
  • Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials, 2021, ESMO Open
  • Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis, 2020, International Journal of Molecular Sciences

Frequent collaborators in their research include:

  • Federica Matteucci
  • Anna Sarnelli
  • Valentina Di Iorio
  • Stefano Severi
  • Paola Caroli

The breadth of publications spans 181 works in medicine, with significant contributions to imaging techniques and oncological studies. The scientist's research presents an emphasis on radiopharmaceutical applications and treatments for prostate cancer alongside investigations into neuroendocrine tumors and lung cancer.

Best Publications

  • A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Alberto Luini

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

    Umberto Veronesi;Giovanni Paganelli;Viviana Galimberti;Giuseppe Viale

  • Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

    U Veronesi;G Paganelli;G Viale;V Galimberti

  • Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

    Umberto Veronesi;Giuseppe Viale;Giovanni Paganelli;Stefano Zurrida

  • Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Giuseppe Viale;Alberto Luini;Alberto Luini

  • Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

    Dik J Kwekkeboom;Jan Mueller-Brand;Giovanni Paganelli;Lowell B Anthony

  • Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions

    Roberto Gennari;Viviana Galimberti;Concetta De Cicco;Stefano Zurrida

  • Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

    Lisa Bodei;Marta Cremonesi;Chiara M. Grana;Nicola Fazio

  • Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

    Lisa Bodei;Marta Cremonesi;Mahila Ferrari;Monica Pacifici

  • Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

    Lisa Bodei;Mark Kidd;Giovanni Paganelli;Chiara M. Grana

  • Radioguided Sentinel Lymph Node Biopsy in Breast Cancer Surgery

    G Mariani;L Moresco;G Viale;G Villa

  • Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy

    David M. Goldenberg;Robert M. Sharkey;Giovanni Paganelli;Jacques Barbet

  • Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: A phase I study

    Lisa Bodei;Marta Cremonesi;Stefania Zoboli;Chiara Grana

  • Three-Step Monoclonal Antibody Tumor Targeting in Carcinoembryonic Antigen-positive Patients

    G. Paganelli;P. Magnani;F. Zito;E. Villa

  • Predicting the Risk for Additional Axillary Metastases in Patients With Breast Carcinoma and Positive Sentinel Lymph Node Biopsy

    Giuseppe Viale;Eugenio Maiorano;Giancarlo Pruneri;Mauro G. Mastropasqua

  • 111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial

    Irene Virgolini;Keith Britton;John Buscombe;Roy Moncayo

  • Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours.

    Lisa Bodei;Marta Cremonesi;Chiara Grana;Paola Rocca

  • Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

    Giovanni Paganelli;Stefania Zoboli;Marta Cremonesi;Lisa Bodei

  • Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.

    Concetta De Cicco;Marta Cremonesi;Alberto Luini;Mirco Bartolomei

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

    U. Veronesi;G. Paganelli;V. Galimberti;G. Viale

Frequent Co-Authors

Giuseppe Viale
Giuseppe Viale University of Milan
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Viviana Galimberti
Viviana Galimberti European Institute of Oncology
Paolo Veronesi
Paolo Veronesi European Institute of Oncology
Giovanni Martinelli
Giovanni Martinelli University of Bologna
Antonio G. Siccardi
Antonio G. Siccardi IRCCS Ospedale San Raffaele
Ugo De Giorgi
Ugo De Giorgi University of Salento
Irvin M. Modlin
Irvin M. Modlin Yale University
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
F. Fazio
F. Fazio University of Milano-Bicocca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can help you enter the workforce faster or expand your career options. Many students consider combining online education with traditional routes to medical careers, thanks to flexibility and affordability.

Nursing remains a highly sought-after field for those interested in patient care. If you’re searching for a cost-effective way to advance, explore cheap rn to bsn programs to study from home while upgrading your credentials. For those who already have a non-nursing bachelor’s degree, direct entry msn online programs offer an accelerated route to advanced nursing roles.

If you’re looking to take your first step into healthcare, you might wonder what is the easiest nursing program to get into. Knowing your options may help open doors to nursing programs suited to your background.

For those more interested in administrative roles, accredited medical billing and coding schools online allow you to train for in-demand jobs without direct patient care. These diverse educational routes support different lifestyles and career goals in the healthcare domain.

Best Scientists Citing Giovanni Paganelli

Trending Scientists

Recently Published Articles